Mitsubishi UFJ Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.4K	Hold	491	–	–	﹤0.01%	1420
2026 Q1	$10.9K	Hold	491	–	–	﹤0.01%	1368
2025 Q4	$12.9K	Hold	491	–	–	﹤0.01%	1318
2025 Q3	$10.5K	Hold	491	–	–	﹤0.01%	1333
2025 Q2	$10.6K	Hold	491	–	–	﹤0.01%	1326
2025 Q1	$8.16K	Hold	491	–	–	﹤0.01%	1343
2024 Q4	$9.04K	Hold	491	–	–	﹤0.01%	1314
2024 Q3	$7.55K	Hold	491	–	–	﹤0.01%	1327
2024 Q2	$7.98K	Hold	491	–	–	﹤0.01%	1258
2024 Q1	$9.08K	Hold	491	–	–	﹤0.01%	1177
2023 Q4	$14.5K	Buy	+491	New	+$11.7K	﹤0.01%	1103

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mitsubishi UFJ Asset Management's ACAD Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 491 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Mitsubishi UFJ Asset Management first reported a position in ACAD in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.5K in Q4 2023. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Mitsubishi UFJ Asset Management held 491 shares of Acadia Pharmaceuticals worth $12.4K as of Q2 2026.
Mitsubishi UFJ Asset Management left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1420 holding.
Mitsubishi UFJ Asset Management first reported a position in Acadia Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Mitsubishi UFJ Asset Management's Acadia Pharmaceuticals position peaked at $14.5K in Q4 2023.
354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.